The urgent need for AI governance in healthcare was highlighted during a recent statement in Lisbon, emphasizing the disparity between AI deployment and its regulation.
Despite a growing adoption of AI technologies in healthcare—such as diagnostics and patient chatbots—only 8% of countries in the WHO European Region have a dedicated AI strategy. This stark contrast raises concerns as nearly two-thirds of these countries are already utilizing AI, underscoring a significant gap in governance. The WHO's recent assessment revealed that while improving patient care is a primary motivator for AI adoption, the lack of regulatory frameworks poses risks, including potential biases in algorithms that could lead to misdiagnoses.
Key findings from the WHO assessment indicate that only 20% of countries provide AI education for health professionals prior to qualification, and less than half have evaluated their legal frameworks for AI applicability. Additionally, around 40% of countries lack ethical guidelines for AI use in healthcare. This governance lag not only threatens patient safety but also undermines public trust in healthcare systems.
To address these challenges, three crucial actions were proposed: first, countries must develop comprehensive governance strategies that align with AI deployment; second, collaboration among nations is essential, as demonstrated by the WHO's initiative to unite 37 countries in Lisbon; and third, the Portuguese-speaking community can leverage its historical ties to foster cooperation on AI in health. The future of AI in healthcare hinges on robust frameworks, partnerships, and political commitment to ensure equitable access to its benefits.